US Patent Issued to Allergan on April 14 for "Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,699, issued on April 14, was assigned to Allergan Inc. (Irvine, Calif.).

"Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation" was invented by Xiaojie Yu (Orange, Calif.), Darin J. Messina (Laguna Niguel, Calif.), Elizabeta Pavlovic (Los Angeles), Cunqi Cui (Jurupa Valley, Calif.) and Kate M. Smither (Newbury Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Hydrogels comprising a macromolecular matrix and water may be used to augment soft tissue of a human being, promote or support cell or tissue viability or proliferation, create space in tissue, and for other purpo...